Dual diagnosis: Focusing on depression and recommendations for treatment

Addictive Disorders and their Treatment

Volumn 10, Issue 2, 2011, Pages 50-59

  Torrens, Marta ^a,b   Martínez Sanvisens, Diana ^a,b   Martínez Riera, Roser ^a   Bulbena, Antonio ^a,b   Szerman, Néstor ^c   Ruiz, Pedro ^d  

^a Linea Primaria Salut Mental   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressants; depression; dual diagnosis

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MEMANTINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NALTREXONAZINE; NEFAZODONE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ALCOHOLISM; ARTICLE; COCAINE DEPENDENCE; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; HEROIN DEPENDENCE; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

EID: 79958066207     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e318215f322     Document Type: Article

References (38)

1. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSMIV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64:566-576. (Pubitemid 46718289)
2. Conner KR, Pinquart M, Holbrook AP. Meta-analysis of depression and substance use and impairment among cocaine users. Drug Alcohol Depend. 2008; 98:13-23.
3. Conner KR, Pinquart M, Duberstein PR. Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction. 2008;103:524-534. (Pubitemid 351389274)
4. Conner KR, Pinquart M, Gamble SA. Meta-analysis of depression and substance use among individuals with alcohol use disorders. J Subst Abuse Treat. 2009; 37:127-137.
5. Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry. 2005;162: 1483-1493. (Pubitemid 41105562)
6. Davis L, Uezato A, Newell J, et al. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21:14-18. (Pubitemid 351339802)
7. Hasin D, Nunes EV. Comorbidity of alcohol, drug and psychiatric disorders: epidemiology. Dual diagnosis and treatment. In: Kranzler HR, Tinsley JA, eds. Dual Diagnosis and Psychiatric Treatment. 2nd ed. New York: Marcel Dekker; 2004:1-34.
8. Aharonovich E, Liu X, Nunes E, et al. Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am J Psychiatry. 2002;159:1600-1602. (Pubitemid 35006746)
9. Hasin D, Liu X, Nunes E, et al. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59: 375-380. (Pubitemid 34275256)
10. Hasin D, Samet S, Nunes E, et al. Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. Am J Psychiatry. 2006;163:689-696. (Pubitemid 44464580)
11. Grant BF, Stinson F, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:807-816. (Pubitemid 39031120)
12. Torrens M, Gilchrist G, Domingo-Salvany A, et al. Psychiatric comorbidity in illicit drug users: substance- induced versus independent disorders. Drug Alcohol Depend. 2011;113:147-156.
13. Niciu MJ, Chan G, Gelernter J, et al. Subtypes of major depression in substance dependence. Addiction. 2009;104:1700-1709.
14. Pani PP, Maremmani I, Trogu E, et al. Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? J Affect Disord. 2010;122:185-197.
15. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA. 2004;291:1887-1896. (Pubitemid 38509503)
16. Torrens M, Fonseca F, Mateu G, et al. Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic reviewand meta-analysis. Drug Alcohol Depend. 2005;78:1-22. (Pubitemid 40354172)
17. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry. 2006; 67:1104-1109. (Pubitemid 44230882)
18. Altintoprak A, Zorlu N, Coskunol H, et al. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Hum Psychopharmacol. 2008;23:313-319. (Pubitemid 351982668)
19. Brown R, Niaura R, Lloyd-Richardson E, et al. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res. 2007;9:721-730. (Pubitemid 47009227)
20. Catley D, Harris K, Okuyemi S, et al. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine Tob Res. 2005;7:859-870. (Pubitemid 43101704)
21. Cinciripini P, Tsoh J, Wetter D, et al. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. Exp Clin Psychopharmacol. 2005;13:282-292. (Pubitemid 43011153)
22. Ciraulo D, Knapp C, Rotrosen J, et al. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms. Addiction. 2005;100(suppl 1): 23-31. (Pubitemid 40363422)
23. Cook J, Spring B, McChargue D, et al. Influence of fluoxetine on positive and negative affect in a clinicbased smoking cessation trial. Psychopharmacology. 2004;173:153-159. (Pubitemid 38591160)
24. Kranzler H, Mueller T, Cornelius J, et al. Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol. 2006; 26:13-20. (Pubitemid 43167084)
25. Levin F, Bisaga A, Raby W, et al. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. J Subst Abuse Treat. 2008;34:80-89. (Pubitemid 350216351)
26. McDowell D, Nunes E, Seracini A, et al. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend. 2005;80:209-221. (Pubitemid 41427635)
27. Muhonen LH, Lahti J, Sinclair D, et al. Treatment of alcohol dependence in patients with co-morbid major depressive disorder: predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy. 2008;3:20.
28. Muhonen LH, Lonnqvist J, Juva K, et al. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry. 2008;69:392-399. (Pubitemid 351549391)
29. Saules KK, Schuh LM, Arfken CL, et al. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. Am J Addictions. 2004;13:438-446. (Pubitemid 39603289)
30. Pettinati HM, Oslin DW, Kampman KM, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry. 2010;167:668-675.
31. Cox L, Patten C, Niaura R, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med. 2004;19:828-834. (Pubitemid 39096354)
32. Cinciripini P, Wetter D, Tomlinson G, et al. The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood. Nicotine Tob Res. 2004; 6:229-239. (Pubitemid 38678853)
33. Brown C, Schulberg H, Shear M. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice. Anxiety. 1996;2:210-218. (Pubitemid 126812830)
34. van Broekhoven F, Kan C, Zitman F. Dependence potential of antidepressants compared to benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:939-943. (Pubitemid 35245563)
35. Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol. 1999;13: 300-307. (Pubitemid 29435798)
36. Volkow N, Wang G, Fowler J, et al. The slow and longlasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects. Biol Psychiatry. 2005;57:640-646. (Pubitemid 40409702)
37. Jasinski D, Faries D, Moore R, et al. Abuse liability assessment of atomoxetine in a drug-abusing population. Drug Alcohol Depend. 2008;95:140-146.
38. Nunes E, Levin F. Treatment of co-occurring depression and substance dependence: using meta-analysis to clinical recommendations. Psychiatr Ann. 2008; 38:730-738.